Know Cancer

or
forgot password

Radiation Induced Change of Liver Function Measured by Uptake of the Galactose Analogue FDGal and PET/CT


N/A
18 Years
85 Years
Open (Enrolling)
Both
Hepatocellular Carcinoma, Cholangiocarcinoma, Metastases, Stereotactic Body Radiotherapy

Thank you

Trial Information

Radiation Induced Change of Liver Function Measured by Uptake of the Galactose Analogue FDGal and PET/CT


Inclusion Criteria:



- liver tumor

- referred for stereotactic radiation therapy

- age > 18 years

Exclusion Criteria:

- Impaired kidney function

- Pregnancy

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Uptake of FDGal

Outcome Description:

Volumetric uptake of FDGal can be measured is measured by PET/CT

Outcome Time Frame:

Before, 1 month and 3 months after stereotactic radiotherapy

Safety Issue:

No

Principal Investigator

Morten Høyer, MD PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Aarhus University Hospital

Authority:

Denmark: National Board of Health

Study ID:

AarhusLiverRadGal

NCT ID:

NCT01213758

Start Date:

June 2010

Completion Date:

May 2013

Related Keywords:

  • Hepatocellular Carcinoma
  • Cholangiocarcinoma
  • Metastases
  • Stereotactic Body Radiotherapy
  • liver function
  • galactose
  • 18-F-deoxy-galactose
  • PET/CT
  • stereotactic body radiation therapy
  • SBRT
  • Carcinoma
  • Neoplasm Metastasis
  • Cholangiocarcinoma
  • Carcinoma, Hepatocellular

Name

Location